Trinity Biotech | TRIB - Ebitda


Trinity Biotech reported $-9.6M in EBITDA for its fiscal quarter ending in December of 2024.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
EDAP TMS EUR -5.77M 228K Jun/2025
J&J USD 9.52B 389M Sep/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
OraSure Technologies USD 920K 9.87M Jun/2024
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.64B 535M Dec/2025
Surmodics USD 1.53M 485K Sep/2024
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Tosoh JPY 39.13B 286M Dec/2024
Trinity Biotech USD -9.6M 7.64M Dec/2024
Veracyte USD 39.73M 3.96M Sep/2025